Back

Personalised approach to hypertension treatment: Rationale and design of the HYPERMARKER randomised trial

2026-02-05 cardiovascular medicine Title + abstract only
View on medRxiv
Show abstract

Background and ObjectiveBlood pressure treatment response is variable in individual patients, and the choice of medical therapy is often dependent on clinician experience. Treatment choices can be personalised by patient empowerment, metabolomic profiles and augmented by machine learning, but robust evaluation is lacking on how these can be combined to enhance clinical effectiveness. The HYPERMARKER trial will evaluate how an individualised choice of medication class can address the avoidable gl...

Predicted journal destinations